PRESS RELEASE published on 04/30/2024 at 18:00, 1 year 7 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.24. ABIVAX communique le nombre d'actions et de droits de vote au 31.03.24, conformément aux dispositions réglementaires. Abivax est une société de biotechnologie axée sur le développement de traitements thérapeutiques Droits De Vote Capital Social Biotechnologie Abivax Traitements Thérapeutiques
BRIEF published on 04/05/2024 at 22:05, 1 year 8 months ago Abivax Announces Submission of Financial Reports to French and U.S. Regulatory Agencies Abivax Financial Reports Chronic Inflammatory Diseases Regulatory Agencies Webcast Announcement
BRIEF published on 04/05/2024 at 22:05, 1 year 8 months ago Abivax annonce la soumission de rapports financiers aux agences de régulation françaises et américaines Abivax Maladies Inflammatoires Chroniques Rapports Financiers Les Organismes De Réglementation Annonce De Diffusion Web
PRESS RELEASE published on 04/05/2024 at 22:00, 1 year 8 months ago Abivax a déposé ses rapports financiers auprès des autorités de marchés financiers française et américaine Abivax dépose ses rapports financiers auprès des autorités de marchés français et américaine, annonçant la disponibilité de ses documents pour l'année 2023 Biotechnologie Abivax Investisseurs Rapports Financiers Autorités De Marchés
PRESS RELEASE published on 04/05/2024 at 22:00, 1 year 8 months ago Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes 2023 financial reports with French and U.S. securities regulators, including annual report and governance information Abivax Financial Reports Regulatory Agencies French Securities U.S. Securities
BRIEF published on 04/02/2024 at 08:35, 1 year 8 months ago Abivax Reports 2023 Financial Results and Operational Update Financial Results Abivax Obefazimod Ulcerative Colitis Nasdaq IPO
BRIEF published on 04/02/2024 at 08:35, 1 year 8 months ago Abivax publie ses résultats financiers 2023 et un point opérationnel Résultats Financiers Abivax Obefazimod Rectocolite Hémorragique Introduction En Bourse Au Nasdaq
PRESS RELEASE published on 04/02/2024 at 08:30, 1 year 8 months ago Abivax reports 2023 financial results and operational update Abivax reports 2023 financial results & operational update. Raised EUR 500M, aims to finance operations till Q4 2025. Webcast on April 8, 2024 Financial Results Fundraising Abivax Webcast Operational Update
PRESS RELEASE published on 04/02/2024 at 08:30, 1 year 8 months ago Abivax publie ses résultats annuels 2023 et présente un point d’avancement sur l’activité Abivax publie ses résultats annuels 2023 et présente un point d'avancement sur l'activité, démontrant une forte croissance financière et des progrès dans ses programmes cliniques Croissance Financement Abivax Résultats Annuels 2023 Programmes Cliniques
BRIEF published on 03/27/2024 at 18:05, 1 year 8 months ago ABIVAX publie son nombre d’actions et de droits de vote au 29 février 2024 Euronext Paris Droits De Vote Capital Social Abivax Réglementation
Published on 12/06/2025 at 20:10, 10 hours 11 minutes ago New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth
Published on 12/06/2025 at 02:00, 1 day 4 hours ago Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 1 day 5 hours ago Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 1 day 5 hours ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 1 day 6 hours ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/06/2025 at 18:08, 12 hours 12 minutes ago EQS-Adhoc: Klöckner & Co SE: Klöckner & Co SE confirms rumors on negotiations regarding a potential voluntary public takeover offer by Worthington Steel, Inc.
Published on 12/06/2025 at 17:50, 12 hours 30 minutes ago Yidan Prize Foundation connects global insights and local expertise at annual flagship Summit
Published on 12/06/2025 at 16:45, 13 hours 35 minutes ago Blokees exhibits at CCXP25 in Brazil: World Premiere of the New Saint Seiya Product
Published on 12/06/2025 at 16:30, 13 hours 50 minutes ago Döhler Opens New R&D Centre in Shanghai to Accelerate Innovation across Asia-Pacific
Published on 12/05/2025 at 22:15, 1 day 8 hours ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/06/2025 at 13:26, 16 hours 54 minutes ago Total number of voting rights and shares making up the share capital at November30, 2025
Published on 12/06/2025 at 13:26, 16 hours 54 minutes ago Capital et droits de vote au 30 novembre 2025
Published on 12/05/2025 at 23:00, 1 day 7 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 day 7 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 day 7 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
